More positive coverage
Impedimed has flagged potential new markets for its device, such as monitoring a build up of heart fluid.
"This is a much larger potential market, therefore 2016 could be transformational for Impedimed," Smith said, where he has a $1.90 price target.
http://www.theage.com.au/business/m...l-biotechs-20151228-glvrek.html#ixzz3wHBpEj77
trending upwards, page-2
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $93.06M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.6¢ | $24.00K | 521.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 398155 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 155675 | 4 |
View Market Depth
| Last trade - 11.54am 06/09/2024 (20 minute delay) ? |
| IPD (ASX) Chart |